Authors:
Archimbaud, E
Ottmann, OG
Yin, JAL
Lechner, K
Dombret, H
Sanz, MA
Heil, G
Fenaux, P
Brugger, W
Barge, A
O'Brien-Ewen, C
Matcham, J
Hoelzer, D
Citation: E. Archimbaud et al., A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as anadjunct to chemotherapy for adults with de novo acute myeloid leukemia, BLOOD, 94(11), 1999, pp. 3694-3701